News Conference News ESC 2025 HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients Caitlin E. Cox September 01, 2025
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Daily News Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients L.A. McKeown June 29, 2022
News Daily News SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE Todd Neale June 23, 2021
News Daily News Thrombotic Events Frequent Among COVID-19 Patients in ICUs Michael O'Riordan October 27, 2020
News Daily News In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate Yael L. Maxwell July 21, 2020
News Daily News Rivaroxaban May Yet Protect After a Hospital Stay: MARINER Caitlin E. Cox June 25, 2020
News Daily News How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions Michael O'Riordan April 22, 2020
News Daily News Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients Yael L. Maxwell April 11, 2017